Metraipolis › archive › dc_1bb9371eba01

Patient perspectives on SLE, refractory APS, and biologic drug use during pregnancy — Europe PMC PMID:41885718

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41885718
DOI
10.1177/09612033261437466
License (as archived)
solo-consultazione
Archived
2026-11-03T20:42:02.515Z
SHA-256 of the archived text
c13a73f63b4a9a4f790807683e920b8cd3fd7559be5cffb70cce4ce1d36ba21f
Stable URL of this page
https://metraipolis.com/documento/dc_1bb9371eba01

How to cite

Patient perspectives on SLE, refractory APS, and biologic drug use during pregnancy — Europe PMC PMID:41885718 — Europe PMC (en), https://europepmc.org/article/MED/41885718 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1bb9371eba01 (Metraipolis archive dc_1bb9371eba01, sha256 c13a73f63b4a9a4f790807683e920b8cd3fd7559be5cffb70cce4ce1d36ba21f)
BibTeX
@misc{dc1bb9371eba01,
  title = {Patient perspectives on SLE, refractory APS, and biologic drug use during pregnancy — Europe PMC PMID:41885718},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41885718},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1bb9371eba01; sha256 c13a73f63b4a9a4f790807683e920b8cd3fd7559be5cffb70cce4ce1d36ba21f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41885718. Agents can read the archived copy with the MCP tool read_document.